In conclusion, the anti-cancer effects of QFM combined with PD-1 inhibitor are mainly through inhibiting activation of STAT1/IDO1-mediated tryptophan-kynurenine pathway and down-regulating expression of PD-1. The gene discussed is IDO1; the disease is cancer.